The "Made in Vietnam" Nano Covax vaccine will begin the third phase of clinical trials this week.
|The Nano Covax vaccine will be tested on 15,000 volunteers |
In the third phase, the Nano Covax vaccine will be tested at many centres in the country with about 13,000 volunteers. In particular, clinical trials will be conducted at the Military Medical Academy and Hung Yen in the north, as well as the Pasteur Institute in Ho Chi Minh City and Long An in the south.
As of the early afternoon of June 7, more than 6,000 people had registered for the third phase trial of the vaccine. According to Vietnam Military Medical University, the number of volunteers is increasing rapidly every hour, with more than 5,000 people signing up in the past 10 days.
The results of the first two phases of trial showed that the Nano Covax vaccine was safe, 100 per cent of the volunteers produced antibodies from tens to hundreds of times, much higher than expected. The vaccine is effective against the British and South African variants. The effect against the Indian variant will continue to be studied in the thidr phase.
Nano Covax has been developed by Nanogen since May 2020. To date, the Nano Covax vaccine has undergone two phases of clinical trials, the first starting in last December and the second starting on February 26, 2021.